Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640

Fluorometric assay of proteins in the nanogram range

Böhlen, P., Stein, S., Dairman, W. M., & Udenfriend, S. (1973) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(73)80023-2 · Cited by 1,632

Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity

Zhang, J., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1994) · Science · doi:10.1126/science.8080500 · Cited by 1,118

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962

Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced

Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961

Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.

Frei, B. B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 623

Alternative excitotoxic hypotheses

Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574

Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites

Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hänicke, W., & Sauter, R. (1989) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910110105 · Cited by 522

Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Shoffner, J. M., Lott, M. T., Voljavec, A. S., Soueidan, S. A., Costigan, D. A., & Wallace, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7952 · Cited by 507

Targeting cellular energy production in neurological disorders

Baker, S. K., & Tarnopolsky, M. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.10.1655 · Cited by 43

Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the melas syndrome

Majamaa, K., Rusanen, H., Remes, A. M., Pyhtinen, J., & Hassinen, I. E. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)80008-7 · Cited by 42

Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and non-diabetic Fischer 344 rats

Sakakibara, Y., Mitha, A. P., Ayoub, I. A., Ogilvy, C. S., & Maynard, K. I. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02263-1 · Cited by 42

Huntington's disease: progress and potential in the field

Stack, E. C., & Ferrante, R. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.12.1933 · Cited by 39

Effect of Nicotinamide Against Candida albicans

Xing, X., Liao, Z., Tan, F., Zhu, Z., Jiang, Y., & Cao, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00595 · Cited by 38

Therapeutic window for nicotinamide following transient focal cerebral ischemia

Ayoub, I. A., & Maynard, K. I. (2002) · Neuroreport · doi:10.1097/00001756-200202110-00008 · Cited by 38

Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection

Kincses, Z. T., & Vécsei, L. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00150.x · Cited by 39

Effect of lead toxicity on coenzyme Q levels in rat tissues

Abd‐Allah, G. M., El‐Sayed, E. M., & Abo‐Salem, O. M. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.04.006 · Cited by 37

Role of superoxide in poly(ADP-ribose) polymerase upregulation after transient cerebral ischemia

Narasimhan, P., Fujimura, M., Noshita, N., & Chan, P. H. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00062-7 · Cited by 37

Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP

Albers, D. S., Zeevalk, G. D., & Sonsalla, P. K. (1996) · Brain Research · doi:10.1016/0006-8993(96)00135-7 · Cited by 35

Amelioratory effect of coenzyme Q10 on potential human carcinogen Microcystin-LR induced toxicity in mice

Lone, Y., Bhide, M., & Koiri, R. K. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.02.018 · Cited by 32

Nicotinamide: A Nutritional Supplement that Provides Protection Against Neuronal and Vascular Injury

Lin, S., Chong, Z. Z., & Maiese, K. (2001) · Journal of Medicinal Food · doi:10.1089/10966200152053686 · Cited by 31

The Effects of Topical Coenzyme Q10 and Vitamin E d -α-Tocopheryl Polyethylene Glycol 1000 Succinate after Cataract Surgery: A Clinical and in vivo Confocal Study

Fogagnolo, P., Sacchi, M. M., Ceresara, G., Paderni, R., Lapadula, P., Orzalesi, N., & Rossetti, L. M. (2012) · Ophthalmologica · doi:10.1159/000342196 · Cited by 30

Optic Nerve Neuroprotection in Glaucoma: A Narrative Review

D’Angelo, A., Vitiello, L., Lixi, F., Abbinante, G., Coppola, A., Gagliardi, V., Pellegrino, A., & Giannaccare, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082214 · Cited by 29

Emerging chemotherapeutic strategies for Huntington’s disease

Ryu, H., & Ferrante, R. J. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.345 · Cited by 30

Late onset familial dystonia: could mitochondrial deficits induce a diffuse lesioning process of the whole basal ganglia system?

Caparros-Lefebvre, D., Destée, A., & Petit, H. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.2.196 · Cited by 28

Coenzyme Q10 and its effects in the treatment of neurodegenerative diseases

dos Santos, G. C., Antunes, L. M. G., dos Santos, A. C., & Bianchi, M. D. L. P. (2009) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502009000400002 · Cited by 28

Effect of coenzyme Q10 supplementation on diabetes induced memory deficits in rats

Omidi, G., Karimi, S. A., Rezvani-Kamran, A., Monsef, A., Shahidi, ‬., & Komaki‬, A. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00402-7 · Cited by 27

Delayed Multidose Treatment with Nicotinamide Extends the Degree and Duration of Neuroprotection by Reducing Infarction and Improving Behavioral Scores up to Two Weeks Following Transient Focal Cerebral Ischemia in Wistar Rats

Maynard, K. I., Ayoub, I. A., & Shen, C. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03653.x · Cited by 26

Protection of cultured oligodendrocytes against tumor necrosis factor-α by the antioxidants coenzyme Q10 and N-acetyl cysteine

Cammer, W. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00830-4 · Cited by 25

2‐Deoxy‐D‐Glucose Prevents and Nicotinamide Potentiates 3,4‐Methylenedioxymethamphetamine‐Induced Serotonin Neurotoxicity

Hervías, I., Lasheras, B., & Aguirre, N. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750982.x · Cited by 25

Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction

Tanaka, M., & Vécsei, L. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02812-z · Cited by 23

Nicotinamide: Bright Potential in Glaucoma Management

Babighian, S., Gattazzo, I., Zanella, M. S., Galan, A., D’Esposito, F., Musa, M., Gagliano, C., Lapenna, L., & Zeppieri, M. (2024) · Biomedicines · doi:10.3390/biomedicines12081655 · Cited by 20

Nicotinamide Modulates Energy Utilization and Improves Functional Recovery from Ischemia in the In Vitro Rabbit Retina

Tam, D. Y., Tam, M., & Maynard, K. I. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00033.x · Cited by 20

Plasma Levels of Coenzyme Q10 in Children with Hyperthyroidism

Menke, T., Niklowitz, P., Reinehr, T., de Sousa, G., & Andler, W. (2003) · Hormone Research in Paediatrics · doi:10.1159/000075670 · Cited by 20

Experimental Models of HD and Reflection on Therapeutic Strategies

Kim, J., Bordiuk, O. L., & Ferrante, R. J. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00016-x · Cited by 20

Influence of exercise-induced oxidative stress on the central nervous system

Somani, S. M., & Husain, K. M. (2000) · Elsevier eBooks · doi:10.1016/b978-044482650-3/50026-2 · Cited by 19

Nutritional deficiencies, metabolic disorders and toxins affecting the nervous system

Harris, J., Chimelli, L. M. C., Kril, J. J., & Ray, D. E. (2008) · CRC Press eBooks · doi:10.1201/b13319-11 · Cited by 17

Toxin-induced mitochondrial dysfunction

Browne, S. E., & Beal, M. F. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53010-5 · Cited by 17

Neurodegeneration and Aging of the Central Nervous System

Blaylock, R. L. (1998) · Integrative medicine · doi:10.1016/s1096-2190(98)00032-8 · Cited by 17

Imaging focal reperfusion injury following global ischemia with diffusion-weighted magnetic resonance imaging and 1H-Magnetic Resonance Spectroscopy

Bizzi, A., Righini, A., Turner, R., Bihan, D. L., Bockhorst, K. H. J., & Alger, J. R. (1996) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(96)00094-x · Cited by 17

Huntington's disease

Bonelli, R. M., & Beal, M. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00030-9 · Cited by 16

Coenzyme Q10 supplementation reverses diabetes-related impairments in long-term potentiation induction in hippocampal dentate gyrus granular cells: An in vivo study

Omidi, G., Karimi, S. A., Shahidi, ‬., Faraji, N., & Komaki‬, A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146475 · Cited by 15

Is Coenzyme Q10 Effective in Protection against Ulcerative Colitis? An Experimental Study in Rats

Ewees, M. G., Messiha, B. A. S., Abo‐Saif, A. A., & El-Latif, H. A. E.-T. A. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00124 · Cited by 15

Neuroprotective and neurorestorative strategies for neuronal injury

Beal, M. F., Palomo, T., Kostrzewa, R. M., & Archer, T. (2000) · Neurotoxicity Research · doi:10.1007/bf03033786 · Cited by 14

Cell Culture Models of Neuronal Degeneration and Neuroprotection

Leonardi, E. T. K., & Mytilineou, C. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_12 · Cited by 14

Rotenone-induced Parkinson`s Like Disease: Modulating Role of Coenzyme Q10

., H. M. A.-E. G., Abdallah, D. M., & El-Abhar, H. S. (2004) · Journal of Biological Sciences · doi:10.3923/jbs.2004.568.574 · Cited by 12

Neuroprotective possibilities for Huntington’s disease

Emerich, D. F. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.3.467 · Cited by 12

Therapeutic application of nicotinamide: As a potential target for inhibiting fibrotic scar formation following spinal cord injury

Zhang, C., Shao, Q., Zhang, Y., Liu, W., Kang, J., Jin, Z., Huang, N., & Ning, B. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14826 · Cited by 11

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying

KONES, R. J. (2010) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s12082 · Cited by 11

Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression

Pienaar, I. S., & Chinnery, P. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.010 · Cited by 11

Association of the COQ2 V393A Variant with Parkinson's Disease: A Case-Control Study and Meta-Analysis

Yang, X., Xi, J., Zhao, Q., Jia, H., An, R., Liu, Z., & Xu, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130970 · Cited by 11

Neuroprotective efficacy of nano‐CoQ against propionic acid toxicity in rats: Role of BDNF and CREB protein expressions

Alhusaini, A. M., Hasan, I. H., Alrumayyan, B., Alesikri, M., Alanazi, K., Almasoud, R., & Almarshad, S. N. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22449 · Cited by 11

Restoration of cellular energetic balance with l-carnitine in the neuro-bioenergetic approach for cancer prevention and treatment

Hoang, B. X., Shaw, D. G., Pham, P., & Levine, S. A. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.11.049 · Cited by 11

Coenzyme Q10 Does Not Prevent Oral Dyskinesias Induced by Long-Term Haloperidol Treatment of Rats

Andreassen, O. A., Weber, C., & Jørgensen, H. A. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00118-5 · Cited by 10

Gastroprotective Efficacy of Coenzyme Q10 in Indomethacin-Induced Gastropathy: Other Potential Mechanisms

Malash, A. M., Abdallah, D. M., Agha, A. M., & Kenawy, S. A. (2012) · Ulcers · doi:10.1155/2012/957898 · Cited by 10

Co-administration of chloroquine and coenzyme Q10 improved treatment outcome during experimental cerebral malaria

Ouko, D. B., Amwayi, P. W., Ochola, L. A., Wairagu, P. M., Isaac, A. O., & Nyariki, J. N. (2022) · Journal of Parasitic Diseases · doi:10.1007/s12639-022-01468-4 · Cited by 7

Restoration and putative protection in parkinsonism

Archer, T., & Fredriksson, A. (2000) · Neurotoxicity Research · doi:10.1007/bf03033798 · Cited by 7

Polyalanine and Polyglutamine Diseases: Possible Common Mechanisms?

Abu‐Baker, A., & Rouleau, G. A. (2006) · Elsevier eBooks · doi:10.1016/b978-012369462-1/50034-x · Cited by 6

Tyrosine: Food Supplement or Therapeutic Agent?

TYRRELL, H. A. (1998) · Journal of Nutritional & Environmental Medicine · doi:10.1080/13590849861934 · Cited by 6

In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway

Singh, A., Kumar, V., Langeh, U., Kapil, L., Kaur, S., Rana, N., Bhattacharya, A., Singh, R., Bhatti, J. S., & Singh, C. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10217-1 · Cited by 5

Toxin Induced Mitochondrial Dysfunction and Neurodegeneration

Sabri, M. I. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_14 · Cited by 5

Huntington Disease

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5

Clinical and Research Advances in Huntington's Disease

SuttonBrown, M., & Suchowersky, O. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003231 · Cited by 5

Therapeutic Strategies in Alzheimer’s Disease

Beal, M. F. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_49 · Cited by 5

Potential Therapeutic Use of Coenzyme Q10 in Diabetes Mellitus and Its Complications: an Algorithm of Scoping Clinical Review

Al‐Taie, A., Arueyingho, O., & Hafeez, A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00819-1 · Cited by 4

Mechanisms of Neuronal Death in Huntington's Disease

Koliatsos, V. E., Portera‐Cailliau, C., Schilling, G., Borchelt, D. B., Bêcher, M. W., & Ross, C. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_5 · Cited by 4

Oxidative Stress and Sleep Apnoea in Clinically Healthy Infants in the First Year of Life. Oxidativer Stress und Schlafapnoen bei klinisch gesunden Sauglingen

Menke, T., Niklowitz, P., Schlüter, B., Buschatz, D., Trowitzsch, E., & Andler, W. (2003) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1046/j.1439-054x.2003.03198.x · Cited by 4

Huntington’s Disease: Clinical Experimental Therapeutics

Ray, D. E., & Shoulson, I. (2011) · Cited by 3

Bioenergetics in Oxidative Damage in Neurodegenerative Diseases

Beal, M. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_22 · Cited by 3

A therapeutic target and biomarker in Friedreich’s ataxia

Sherer, T., & Greenamyre, J. T. (2000) · Neurology · doi:10.1212/wnl.55.11.1600 · Cited by 3

Mitochondrial Approaches to Neuroprotection

Beal, M. F. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_4 · Cited by 2

Excitotoxicity*

Lau, A., & Tymianski, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01331-2 · Cited by 2

Huntington disease

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00014-7 · Cited by 2

Apoptosis in Huntington disease and animal models

Koliatsos, V. E., Portera‐Cailliau, C., Schilling, G., Borchelt, D. B., Bêcher, M. W., & Ross, C. A. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)06008-4 · Cited by 2

Therapeutics in Huntington’s Disease

Rosas, H. D., & Koroshetz, W. J. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_17 · Cited by 2

Clinical Manifestations and Mechanisms of Action of Environmental Mitochondrial Toxins

Sabri, M. I., Spencer, P. S., Baggia, S., & Ludolph, A. C. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_1 · Cited by 2

Systemic Administration of 3-Nitropropionic Acid

Brouillet, E., Hantraye, P., & Beal, M. F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_16 · Cited by 2

Huntington’s Disease and DRPLA: Two Glutamine Repeat Diseases

Ross, C. A., Bêcher, M. W., & Koliatsos, V. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_23 · Cited by 2

An investigation into the neuroprotective properties of acyclovir

Müller, A. C. (2006) · Cited by 1

Huntington disease

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1

Validation of Dementia Models Employing Neuroimaging Techniques

Vanhoutte, G., Campo, A., & der Linden, A. V. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_11 · Cited by 1

Magnetic resonance spectroscopy of neurodegenerative illness

Jenkins, B. G., Choi, J., & Beal, M. F. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.022 · Cited by 1

A Gain of Function of the Huntington’s Disease and Amyotrophic Lateral Sclerosis-Associated Genetic Mutations May Be a Loss of Bioenergetics

Beal, M. F. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_13 · Cited by 1

Modulation of the JAK2/STAT3 pathway in vivo : understanding reactive astrocyte functional features and contribution to neurodegenerative diseases

Haim, L. B. (2014) · theses.fr (ABES) · doi:10.70675/75a69111z994cz43dfzb795zfeae9ffc88ab · Cited by 1

Advances in Neuroprotection Research for Neurodegenerative Diseases

Götz, M. E., & Riederer, P. F. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8969-7_1 · Cited by 1

The molecular pathogenesis of Huntington’s disease

Turner, C. D. (2009) · UCL Discovery (University College London)

THE ROLE OF P53 IN OXIDATIVE STRESS AND POLYGLUTAMINE NEUROTOXICITY

Dunn, J. C. (2003) · UKnowledge (University of Kentucky)

Strategies of neuroprotection in an in vivo model of retinal degeneration induced by mitochondrial dysfunction

Rojas-Martinez, J. C. (2009) · Texas ScholarWorks (Texas Digital Library)

Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders

Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306

The Neuroprotective Role of Micronutrients in Parkinson’s Disease

Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · doi:10.1201/9781420073522-7

3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum

Borlongan, C. V., & Sanberg, P. R. (2011) · Neuromethods · doi:10.1007/978-1-61779-301-1_5

Oxidative Stress and Huntington’s Disease

Turner, C., & Schapira, A. H. V. (2003) · Oxidative stress and disease · doi:10.1201/9780203912874.ch20

Huntington's Disease

Browne, S. E., & Beal, M. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50051-2

Neuromodulatory Influences of Nutraceuticals on D-galactose Induced Hippocampal Neuronal Metabolic Dysfunction Model

Masoud, M. A., Ahmed-Fari, O. A., & Rizk, H. A. (2020) · Journal of Pharmacology and Toxicology · doi:10.3923/jpt.2020.44.57

The Future of Brain Protection: Natural Alternatives

Maynard, K. I. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0282-1_6

The Neuroprotective Role of Micronutrients in Parkinson’s Disease

Tsika, E., Ischiropoulos, H., & Malkus, K. A. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch2

Malonate

Meldrum, A., Page, K. J., Everitt, B. J., & Dunnett, S. B. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_14

Co-administration of chloroquine and co-enzyme Q10 reduces neurological deficits, brain edema, and breach of the blood-brain barrier in experimental cerebral malaria

Ouko, D. B., Chepukosi, K. W., Amwayi, P. W., Nyandoro, V. M., Isaac, A. O., & Nyariki, J. N. (2026) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2026.100106

Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases

Schulz, J. B., Matthews, R. T., Henshaw, D. R., & Beal, M. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00527-7 · Cited by 155

Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10

Brouillet, E., Henshaw, D. R., Schulz, J. B., & Beal, M. F. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90044-2 · Cited by 23

Malonate produces striatal lesions by indirect NMDA receptor activation

Henshaw, R., Jenkins, B. G., Schulz, J. B., Ferrante, R. J., Kowall, N. W., Rosen, B. R., & Beal, M. F. (1994) · Brain Research · doi:10.1016/0006-8993(94)91412-5 · Cited by 92

Quinolinic Acid Impairs Redox Homeostasis, Bioenergetic, and Cell Signaling in Rat Striatum Slices: Prevention by Coenzyme Q10

Ferreira, F. S., dos Santos, T. M., Júnior, O. V. R., Silveira, J. S., Schmitz, F., & Wyse, Â. T. D. S. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00484-9 · Cited by 12

Coenzyme Q10administration and its potential for treatment of neurodegenerative diseases

Beal, M. F. (1999) · BioFactors · doi:10.1002/biof.5520090222 · Cited by 111